Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial

Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial

Item
http://www.wikidata.org/entity/Q33937415
Vascular calcification: When should we interfere in chronic kidney disease patients and how?Stop chronic kidney disease progression: Time is approachingPhosphate binders in chronic kidney disease: a systematic review of recent data.High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients.Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis.Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA.Dietary Phosphorus Intake and the Kidney.Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.Evaluation of fracture risk in chronic kidney disease.Remediation of Rare Earth Element Pollutants by Sorption Process Using Organic Natural SorbentsThe future of phosphate binders: a perspective on novel therapeutics.Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency.Changes With Lanthanum Carbonate, Calcium Acetate, and Phosphorus Restriction in CKD: A Randomized Controlled Trial.
P2860

Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial

Item
http://www.wikidata.org/entity/Q33937415
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Changes in fibroblast growth f ...... ized, placebo-controlled trial
@ast
Changes in fibroblast growth f ...... ized, placebo-controlled trial
@en
type
label
Changes in fibroblast growth f ...... ized, placebo-controlled trial
@ast
Changes in fibroblast growth f ...... ized, placebo-controlled trial
@en
prefLabel
Changes in fibroblast growth f ...... ized, placebo-controlled trial
@ast
Changes in fibroblast growth f ...... ized, placebo-controlled trial
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Changes in fibroblast growth f ...... ized, placebo-controlled trial
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932